In bringing together global leaders again in 2017 to review advances in the field and update the guidelines, a profound shift in thinking occurred to define Alzheimer's disease biologically, by pathologic brain changes or their biomarkers, and treat cognitive impairment as a symptom / sign of the disease, rather than its definitio
In bringing together global leaders again
in 2017 to review advances in the field and update the guidelines, a profound shift in thinking occurred to define Alzheimer's disease biologically, by pathologic brain changes or their biomarkers, and treat cognitive impairment as a symptom / sign of the disease, rather than its definitio
in 2017 to review advances
in the field and update the guidelines, a profound shift in thinking occurred to define Alzheimer's disease biologically, by pathologic brain changes or their biomarkers, and treat cognitive impairment as a symptom / sign of the disease, rather than its definitio
in the field and update the guidelines, a
profound shift
in thinking occurred to define Alzheimer's disease biologically, by pathologic brain changes or their biomarkers, and treat cognitive impairment as a symptom / sign of the disease, rather than its definitio
in thinking occurred to define Alzheimer's disease biologically, by pathologic brain
changes or their biomarkers, and treat cognitive impairment as a
symptom / sign of the disease, rather than its definition.